EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents

Demokrat Nuha, Asaf Evrim Evren, Begüm Nurpelin Sağlık Özkan, Nalan Gundogdu-Karaburun, Ahmet Çagri Karaburun

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Demokrat Nuha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Alzheimer Disease, Cholinesterase Inhibitors, Drug Design, Phthalazines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of targeted phthalazine‐1,4‐dione acetylcholinesterase (AChE) inhibitors for treating Alzheimer's disease involved the synthesis of 32 compounds via a multistage process. Various analytical techniques confirmed the compounds' identities. Thirteen compounds were found to inhibit AChE by more than 50% without affecting butyrylcholinesterase (BChE). Among these, three compounds, 8m , 8n , and 8p , exhibited extraordinary activity similar to donepezil, a reference AChE inhibitor. During enzyme kinetic studies, compound 8n , displaying the highest AChE inhibitory activity, underwent evaluation at three concentrations (2 × IC 50 , IC 50 , and IC 50 /2). Lineweaver–Burk plots indicated mixed inhibition activity for compound 8n against AChE, suggesting a combination of competitive and noncompetitive characteristics. Additionally, effective derivatives 8m , 8n , and 8p exhibited high blood–brain barrier (BBB) permeability in in vitro parallel artificial membrane permeability assay tests. Molecular docking studies revealed that these compounds bind to the enzyme's active site residues in a position similar to donepezil. Molecular dynamic simulations confirmed the stability of the protein–ligand system, and the chemical reactivity characteristics of the compounds were investigated using density functional theory. The compounds' wide energy gaps suggest stability and therapeutic potential. This research represents a significant step toward finding a potential cure for Alzheimer's disease. However, further research and testing are required to determine the compounds' safety and efficacy. The unique structure of phthalazine derivatives makes them suitable for various biological activities, and these compounds show promise for developing effective drugs for treating Alzheimer's disease. Overall, the development of these targeted compounds is a crucial advancement in the search for an effective treatment for Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCholinesterase InhibitorsDrug DesignPhthalazinesMolecular Docking SimulationAcetylcholinesteraseStructure-Activity RelationshipHumansButyrylcholinesteraseMolecular StructureDonepezilBlood-Brain BarrierDose-Response Relationship, DrugMolecular Dynamics SimulationModels, MolecularAnimals

Stichwörter der Autor:innen

DFT calculationacetylcholinesterase inhibitormolecular dockingmolecular dynamic simulationphthalazine‐1,4‐dione

Substanzen

Cholinesterase InhibitorsPhthalazinesAcetylcholinesteraseButyrylcholinesteraseDonepezil

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • Department of Chemistry, Faculty of Science, Eskisehir Technical University, Eskişehir, Turkey.
  • Faculty of Pharmacy, University for Business and Technology, Prishtina, Kosovo.
  • Vocational School of Health Services, Department of Pharmacy Services, Bilecik Seyh Edebali University, Bilecik, Turkey.

Förderung

  • None

Zitieren

APA

Nuha, D., Evren, A. E., Özkan, B. N. S., Gundogdu-Karaburun, N., & Karaburun, A. Ç. (2024). Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400067

Vancouver

Nuha D, Evren AE, Özkan BNS, Gundogdu-Karaburun N, Karaburun AÇ. Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400067

BibTeX
@article{Nuha2024,
  author = {Nuha, Demokrat and Evren, Asaf Evrim and Özkan, Begüm Nurpelin Sağlık and Gundogdu-Karaburun, Nalan and Karaburun, Ahmet Çagri},
  title = {Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400067}
}
Kostenlos starten →